Clinical trial diversity: It's time to quit talking and start doing

In order to improve diversity in clinical trials, inequities due to economic factors and race need to be bridged at institutional levels.

Related Keywords

Alabama ,United States ,Massachusetts ,Philadelphia ,Pennsylvania ,Illinois ,University Of Pennsylvania ,Chicago ,American ,Clayton Yates ,Carmen Guerra ,Henrietta Lacks ,Lori Minasian ,Melissa Simon ,American Heart Association ,American Society Of Clinical Oncology ,National Cancer Institute ,Clinical Trial Support Services ,Committee On Health ,Cancer Research ,Chicago Cancer Health Equity Collaborative ,Division Of Cancer Prevention ,Department Of Health ,Bristol Myers Squibb ,Tuskegee University ,Department Of Medicine ,Human Services ,Department Of Biology ,Diverse Trials Act ,American Society ,Clinical Oncology ,Clinical Trials Arena ,Deputy Director ,Cancer Prevention ,National Cancer ,New England Journal ,